Melanoma and Other Skin Cancers

ON-TRK: PrOspective Non-Interventional Study in Patients with Locally Advanced or Metastatic TRK Fusion Cancer Treated with Larotrectinib

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry